Join us on Tuesday, July 1, 16:00 CEST

Vasodilatory shock remains a major clinical challenge in critically ill patients. When fluid resuscitation fails to restore adequate perfusion, vasopressors become essential in stabilising hemodynamics. This webinar will delve into the state-of-the-art use of nonadrenergic vasopressors, focusing on agents that act on alternative physiological pathways beyond the adrenergic system—specifically, the vasopressin system and the renin-angiotensin system (RAS).

Key Learning Objectives:

• Review the latest evidence on Angiotensin II and its role in RAS dysfunction
• Get a sneak peek at the results of the PRESS Study and what they mean for clinical practice